A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2018; you can also visit the original URL.
The file type is application/pdf
.
Proteomics as a guiding tool for more effective personalized therapy
2010
Annals of Oncology
Ovarian cancer remains the deadliest gynecological malignancy in the Western world and is most often diagnosed at a rarely curable late stage. Examination of protein end points has been employed as an investigative mechanism to guide targeted therapy and to stratify ovarian cancer. Proteomics allows characterization of the proteins and the associated protein and peptide modifications. This has given us insight into the perturbations of signaling pathways within tumor cells and has improved the
doi:10.1093/annonc/mdq375
pmid:20943616
pmcid:PMC3018888
fatcat:ykfeoylkr5h2rly5riopmwaf6y